The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,588,112 in first-year total cost, median $2,794,056.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BN-M (91)]1
- Special Emphasis Panel[ZRG1 CN-X (85)]1
Most frequent institutions
- BAYLOR COLLEGE OF MEDICINE1
- UNIVERSITY OF ILLINOIS AT CHICAGO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | SARS-CoV-2 initiation and acceleration of AD pathology in the setting of endogenous and exogenous risk factors1RF1NS144213-01 | ANNAPRAGADA, ANANTH VBADACHHAPE, ANDREW ARUNPAREKH, PARAGRONCA, SHANNON | BAYLOR COLLEGE OF MEDICINE, TX | $3,039,032 | ZRG1 |
| 2025 | Impact of SARS-CoV-2 on the cerebrovasculature as a risk factor for VCID: Role of Wnt/beta-catenin1RF1NS138437-01A1 | LUTZ, SARAH ELIZABETH | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $2,549,080 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.